PHAT - Phathom Pharmaceuticals, Inc.

Dashboard

Manage Tickers Link Financial Account

PHATPhathom Pharmaceuticals, Inc.

Nasdaq phathompharma.com

$ 11.35 $ 0.40 (3.65 %)

Friday, 14-Jun-2024 15:59:58 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 479.30 $ 2.47 (0.52 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 94.67 $ 0.79 (0.84 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 11.35

Open

$ 11.00

Bid

$ 11.35 x 100

Ask

$ 0.00 x 0

Day's Range

$ 10.73 - $ 11.40

52 Week Range

$ 6.07 - $ 17.02

Volume

349,826

Average Volume

na

Market Cap

662.52M

Beta (5Y Monthly)

$ 1.04

PE Ratio (TTM)

nm

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-09-2024	03-31-2024	10-Q
2	03-07-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-02-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-11-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-19-2020	12-31-2019	10-K
19	11-25-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Phathom Pharmace...
06/14/2024 12:44:37

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
06/07/2024 12:30:45

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/31/2024 12:26:19

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/24/2024 16:36:47

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/17/2024 13:54:45

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Phathom Pharmaceuticals Will Present VOQUE...
05/15/2024 12:07:23

First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD)1 N...

Needham Reiterates Buy on Phathom Pharmace...
05/10/2024 13:06:50

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

HC Wainwright & Co. Reiterates Buy on Phat...
05/10/2024 12:39:05

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

Needham Reiterates Buy on Phathom Pharmace...
05/09/2024 17:52:41

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Phathom Pharmaceuticals Says It Will Have ...
05/09/2024 12:03:02

Phathom Pharmaceuticals Q1 2024 GAAP EPS $...
05/09/2024 12:01:57

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.42) per share which missed the analyst consensus estimat...

Needham Reiterates Buy on Phathom Pharmace...
05/08/2024 10:03:42

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/03/2024 20:09:18

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Stifel Initiates Coverage On Phathom Pharm...
05/03/2024 09:46:10

Stifel analyst Annabel Samimy initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and announces Pr...

Needham Reiterates Buy on Phathom Pharmace...
04/26/2024 15:16:46

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/19/2024 18:42:01

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/12/2024 14:09:27

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/11/2024 10:27:59

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/05/2024 13:43:30

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/01/2024 11:01:32

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)